GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ansell ANN.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

45.76

+0.22%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$2.19bn

FY2017FY2026

Net income

$213.2m

FY2017FY2026

Free cash flow

$305.1m

FY2017FY2026

Shareholders' equity

$1.99bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$2.19bn$2.00bn$1.62bn$1.66bn$1.95bn$2.03bn$1.61bn$1.50bn$1.49bn$1.37bn
Gross profit$906.3m$825.0m$624.8m$616.7m$625.2m$807.2m$632.7m$584.0m$582.7m$541.2m
Research and development$22.0m$20.8m$16.6m$17.7m$16.6m$14.5m$14.8m$12.2m$27.0m$15.6m
Operating income$343.3m$185.4m$178.9m$210.5m$236.6m$329.9m$222.5m$190.6m$166.1m$162.2m
Net income$213.2m$101.6m$76.5m$148.3m$158.7m$246.7m$158.7m$111.7m$484.3m$147.7m
Diluted earnings per share1.490.700.521.181.251.911.210.843.451.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$3.39bn$3.32bn$3.24bn$2.52bn$2.51bn$2.74bn$2.45bn$2.37bn$2.51bn$2.45bn
Cash and short-term investments$249.4m$238.3m$912.3m$159.0m$206.2m$240.2m$411.5m$396.0m$590.4m$320.5m
Total liabilities$1.37bn$1.34bn$1.33bn$913.1m$949.5m$1.17bn$1.05bn$962.8m$968.7m$1.22bn
Debt$756.3m$805.6m$857.2m$494.0m$485.8m$515.5m$577.5m$545.2m$549.9m$720.5m
Shareholders' equity$1.99bn$1.96bn$1.89bn$1.60bn$1.54bn$1.55bn$1.39bn$1.39bn$1.53bn$1.21bn
Shares outstanding143m145m146m126m127m129m131m133m140m147m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$355.1m$239.3m$272.3m$180.5m$222.0m$172.8m$286.7m$188.9m$153.6m$197.8m
Capital spending−$50.1m−$69.3m−$62.8m−$66.3m−$64.0m−$83.2m−$62.6m−$42.6m−$43.4m−$51.8m
Free cash flow$305.1m$170.0m$209.5m$114.2m$158.0m$89.6m$224.1m$146.3m$110.2m$146.1m
Dividends paid−$80.5m−$63.7m−$53.2m−$62.9m−$86.8m−$77.3m−$63.3m−$58.3m−$58.0m−$61.2m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Mar 2025Dec 2024Jun 2024Dec 2023Jun 2023
Revenue$1.10bn$1.05bn$1.02bn$623.4m$1.02bn$834.4m$784.9m$819.8m
Gross profit$458.8m$426.8m$439.4m$256.0m$398.8m$326.2m$298.6m$311.1m
Operating income$172.5m$142.2m$90.0m$65.2m$127.4m$89.8m$39.5m$117.5m
Net income$118.1m$90.4m$48.3m$66.5m$55.0m$57.1m$19.4m$84.4m
Diluted earnings per share0.830.620.330.460.380.390.150.67
Cash from operations$201.0m$136.0m$104.0m—$88.0m$157.0m$111.0m$113.0m
Capital spending−$18.0m−$29.0m−$41.0m—−$28.0m−$24.0m−$38.0m−$34.0m
Free cash flow$183.0m$107.0m$63.0m—$60.0m$133.0m$73.0m$79.0m
Total assets$3.39bn$3.33bn$3.32bn—$3.27bn$3.24bn$2.53bn$2.52bn
Cash and short-term investments$249.4m$254.2m$238.3m—$268.9m$912.3m$165.1m$159.0m
Debt$678.1m$833.8m$805.6m—$825.7m$857.2m$505.1m$494.0m
Shareholders' equity$1.99bn$1.97bn$1.96bn—$1.91bn$1.89bn$1.57bn$1.60bn

Financial ratios

Data as of 23 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin41.4%41.2%38.6%37.3%32.0%39.8%
Operating margin15.7%9.3%8.0%12.5%12.0%16.7%
Net margin9.7%5.1%4.7%9.0%8.1%12.2%
Return on equity10.7%5.2%4.0%9.3%10.3%15.9%
Return on assets6.3%3.1%2.4%5.9%6.3%9.0%
Free cash flow yield6.1%4.6%5.0%4.2%4.9%4.3%
Revenue growth9.2%23.7%-2.2%-15.2%-3.7%25.6%
Earnings growth109.8%32.8%-48.4%-6.6%-35.7%55.5%
Current ratio2.30x2.13x3.84x2.20x2.73x2.12x
Debt to equity0.34x0.37x0.41x0.27x0.29x0.32x
Equity ratio58.7%59.1%58.4%63.3%61.6%56.7%
Interest coverage7.43x4.47x6.18x11.77x12.83x15.89x
R&D as a share of sales1.0%1.0%1.0%1.1%0.8%0.7%
Buybacks as a share of market value1.7%0.5%-15.9%0.9%1.5%1.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.7%1.5%4.9%
Operating income17.7%0.8%5.4%
Net income12.9%-2.9%3.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin41.3%39.8%38.5%38.7%
Operating margin12.6%12.3%13.0%12.9%
Net margin7.5%7.2%8.3%10.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings21.134.344.414.715.611.519.723.94.416.7
Price to sales2.01.72.11.31.31.41.91.81.41.8

Dividends and splits

Per share, in the currency the company pays

Paid for 23 years. Last went ex-dividend on 31 Aug 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year0.4150.6930.6710.6550.7430.9310.4191.093
  • 5-to-1 reverse split · 15 Apr 2002
  • 11-for-10 split · 22 Sept 1993
  • 1.1-for-1 split · 23 Mar 1989

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.